Signed Option Year 4 Modification SPE2D218-D-0053 P00007.pdf

462 KB Posted

Attached to
SUMATRIPTAN SUCCINATE INJECTABLE
Solicitation number
SPE2D217R0032
Issued by

View the file

Other files

File Type Posted
Option Year 3 Modification SPE2D218D0053 P00006.pdf PDF
Signed P00005 SPE2D218D0053.pdf PDF
Signed SPE2D218D0053 Sumatriptan Succinate Injectable_P00004 (GSMS Signed).pdf PDF
SPE2D218D0053 P00003 Modification to Invoke Option 2 Sumatriptan Succinate (Injectable).pdf PDF
Modification_P00002_to_Invoke_Option_1-_Sumatriptan_Succinate_(Injectable)-_SPE2D2-18-D-0053.pdf PDF
Omeprazole_Award_SPE2D219D0066.pdf PDF
Signed_SPE2D2-18-D-0053_P00001.pdf PDF
SPE2D2-18-D-0053_Sumatriptan_Succinate_Injectable.pdf PDF
Sumatriptan_Succinate_(injectable)_Solicitation_SPE2D217R0032.docx DOCX document
Sumatriptan_Succinate_(injectable)_Solicitation_SPE2D217R0032.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Benjamin Hall, CEO

5/20/2022

2022-05-23T12:41:56-0400
WRAY.JASON.CHRISTOPHER.1238740742
2022-05-23T08:39:33-0700
Benjamin Hall

File details come from the government source that posted it. Updated .